Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
Acta Medica Okayama
|
August 24, 2019
The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
Kenji Kuwaki, Kazuhiro Nouso, Manabi Miyashita, et al.
Acta Medica Okayama
|
March 2, 2019
Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation
Ailee Ikeda, Akinobu Takaki, Tetsuya Yasunaka, et al.
Life (Basel, Switzerland)
|
November 11, 2020
Combined Environment Simulator for Low-Dose-Rate Radiation and Partial Gravity of Moon and Mars
Akihisa Takahashi, Sakuya Yamanouchi, Kazuomi Takeuchi, et al.
Virus Genes
|
May 28, 2016
Two different dengue virus strains in the Japanese epidemics of 2014
Eri Nakayama, Akira Kotaki, Shigeru Tajima, et al.
Cancer Medicine
|
August 4, 2023
The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab
Yasuto Takeuchi, Kazuhiro Nouso, Shin-Ichi Fujioka, et al.
Gastro Hep Advances
|
November 19, 2024
Anti-PD-1 Autoantibody Predicts Survival of Patients With Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab
Yuki Sasaki, Kazuyuki Matsumoto, Akinobu Takaki, et al.
Scientific Reports
|
August 17, 2019
Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4<sup>+</sup> T cells through AMPK activation
Masahiro Takahara, Akinobu Takaki, Sakiko Hiraoka, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 8, 2024
Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab"
Tatsuya Kikuchi, Yasuto Takeuchi, Kazuhiro Nouso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 15, 2024
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab
Tatsuya Kikuchi, Yasuto Takeuchi, Kazuhiro Nouso, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 9, 2026
Borderline Resectable Classification Identifies Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab
Yasuto Takeuchi, Masahiko Sue, Nozomi Miyake, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
Acta Medica Okayama
|
August 24, 2019
The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
Kenji Kuwaki, Kazuhiro Nouso, Manabi Miyashita, et al.
Acta Medica Okayama
|
March 2, 2019
Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation
Ailee Ikeda, Akinobu Takaki, Tetsuya Yasunaka, et al.
Life (Basel, Switzerland)
|
November 11, 2020
Combined Environment Simulator for Low-Dose-Rate Radiation and Partial Gravity of Moon and Mars
Akihisa Takahashi, Sakuya Yamanouchi, Kazuomi Takeuchi, et al.
Virus Genes
|
May 28, 2016
Two different dengue virus strains in the Japanese epidemics of 2014
Eri Nakayama, Akira Kotaki, Shigeru Tajima, et al.
Cancer Medicine
|
August 4, 2023
The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab
Yasuto Takeuchi, Kazuhiro Nouso, Shin-Ichi Fujioka, et al.
Gastro Hep Advances
|
November 19, 2024
Anti-PD-1 Autoantibody Predicts Survival of Patients With Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab
Yuki Sasaki, Kazuyuki Matsumoto, Akinobu Takaki, et al.
Scientific Reports
|
August 17, 2019
Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4<sup>+</sup> T cells through AMPK activation
Masahiro Takahara, Akinobu Takaki, Sakiko Hiraoka, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 8, 2024
Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab"
Tatsuya Kikuchi, Yasuto Takeuchi, Kazuhiro Nouso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 15, 2024
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab
Tatsuya Kikuchi, Yasuto Takeuchi, Kazuhiro Nouso, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 9, 2026
Borderline Resectable Classification Identifies Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab
Yasuto Takeuchi, Masahiko Sue, Nozomi Miyake, et al.
Page
of 11